Erick Espinosa

Background

About Erick Espinosa

Biotechnology Engineer with over 8 years of experience in the development and validation of analytical methods for the quantification of small molecules (LC-MS/MS) and biotechnological products (LBA). Master in Clinical Research with a specialization in clinical pharmacology. Thesis: Characterization of the pharmacokinetic and pharmacodynamic parameters of two insulin products, one reference and one test, in healthy subjects, with the subcutaneous administration of 0.1 U/Kg of regular insulin. Current Roles: IRB member since 2018. Thesis advisor, master in clinical research. Senior bioanalytical scientist for bioequivalence and biosimilarity studies. Notable Achievements: Implementation of immunogenicity area for the analytical evaluation of antidrug antibodies (ADA) to biotechnological products. Experience in more than 30 bioequivalence and biosimilarity studies with different molecules, including drugs, biotech products, and anti-drug antibodies. Participation in the review of ethical compliance and methodological design of more than 50 clinical studies phase I to phase IV as an IRB member. Key Skills: Goal-oriented. 🧠 Analytical ability and problem-solving. Leadership and teamwork coordination. Self-taught. Staff training.